Abbott
At Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world - in nutrition, diagnostics, medical devices and branded generic pharmaceuticals - that create more possibilities for more people at all stages of life. Today, 73,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.
Business & Industry
- Amgen and UCB receive positive vote from FDA Advisory Committee in favor of approval for EVENITY™ (romosozumab)
- Merck welcomes ten new startups to its Innovation Center
- Abbott to acquire Cephea Valve Technologies, Inc.
- European Commission approves Opdivo (nivolumab) plus low-dose Yervoy (ipilimumab) for first-line treatment of patients with intermediate- and poor-risk advanced renal cell carcinoma
- US FDA accepts regulatory submissions for review of tafamidis to treat transthyretin amyloid cardiomyopathy
Research & Development
- Smart microrobots that can adapt to their surroundings
- Nanoparticle breakthrough in the fight against cancer
- Sleeping less than six hours a night may increase cardiovascular risk
- Muscle stem cells can drive cancer that arises in Duchenne muscular dystrophy
- Danish malaria vaccine passes test in humans
- Stem cell study offers clues for optimizing bone marrow transplants and more
- Researchers uncover new mechanism of gene regulation involved in tumor progression
Conferences & Events
- SMi presents the 2nd Annual Conference: Injectable Drug Delivery 2019
- 21st Annual Superbugs & Superdrugs Conference
- SMi Group announces the 10th Annual RNA Therapeutics Conference
- Pre-Filled Syringes & Injectable Drug Devices Europe 2018
- Social Media in the Pharmaceutical Industry Conference 2019
- Lyophilization USA Conference 2018
- SMi presents the 13th annual industry leading conference: Cold Chain Distribution
Regulatory Affairs
- FDA approves first treatment for rare blood disease
- FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs
- FDA approves first treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder
- FDA approves new treatment for patients with acute myeloid leukemia
- FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilot